This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Asia: Oligonucleotide & Peptide Therapeutics

Register by January 24 to save up to $300

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
26-28 Feb, 2025
Westin Miyako KyotoKyoto, Japan

Dinesh Parmar
Associate Director Regulatory Affairs at PolyPeptide Group
Speaker

Profile

Dinesh Parmar has 16+ year of working experience in API Regulatory affairs and currently associated with PolyPeptide Group for last 4 years. In his career he has filed 50+ USDMF and worked on critical deficiencies from various Health authorities including but not limited to US, EU, Canada, China, and South Korea. His expertise in Life cycle management of product have been helping organization to strategize the future changes in effective manner, bring quicker consensus with customer and faster approval with regulatory agencies, which results in smooth commercialization of product.

He believes Regulatory intelligence is key for business continuity and aids in keeping organization ahead of time.

Agenda Sessions

  • Impurities in Peptide Drug Substance and Challenges Faced during Registration (in US, EU, Brazil and China Markets) and Commercial Phase

    11:30am